ROBINS CHAD M

CIK 00017806493 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001780649

Recent Transactions

50 trades

Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-01-05$15.59/sh−124,998→ 2,584,243 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-01$18.94/sh−124,998→ 2,709,241 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-26$19.68/sh−35,736→ 2,834,239 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-12$15.00/sh−1,867→ 2,869,975 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-11$14.57/sh−1,237→ 2,871,851 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-10$14.73/sh−86,161→ 2,873,088 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-06$7.64/sh−102,218→ 2,959,249 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.98/sh−81,206→ 2,850,495 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.99/sh−36,145→ 2,814,350 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05+247,117→ 3,061,467 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-04+355,000→ 2,931,701 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-02-20$8.44/sh−99,107→ 2,576,701 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-02-20−99,107→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-02-20$6.32/sh+99,107→ 2,675,808 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-02-19−186,080→ 99,107 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-02-19$6.32/sh+186,080→ 2,762,781 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-02-19$8.46/sh−186,080→ 2,576,701 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-02-18−211,160→ 285,187 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-02-18$6.32/sh+211,160→ 2,787,861 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-02-18$8.50/sh−211,160→ 2,576,701 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-02-14−158,921→ 496,347 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-02-14$8.46/sh−158,921→ 2,576,701 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-02-14$6.32/sh+158,921→ 2,735,622 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-02-13$6.32/sh+100,287→ 2,676,988 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-02-13$8.44/sh−100,287→ 2,576,701 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-02-13−100,287→ 655,268 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.43/sh−42,794→ 2,576,701 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.44/sh−5,879→ 2,619,495 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-04+354,610→ 2,625,374 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06+354,610→ 2,270,764 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2022-03-09−14,815→ 755,555 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-09$12.46/sh−14,815→ 1,916,154 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-09$6.32/sh−14,815→ 1,930,969 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2022-03-08−14,815→ 770,370 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-08$11.38/sh−14,815→ 1,916,154 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-08$6.32/sh−14,815→ 1,930,969 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-07$11.53/sh−14,315→ 1,916,154 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-07$6.32/sh+14,815→ 1,930,969 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2022-03-07−14,815→ 785,185 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-07$12.22/sh−500→ 1,930,469 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-07$12.01/sh−4,424→ 1,916,154 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-04+247,117→ 1,920,578 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-09-10$38.37/sh−4,902→ 1,673,559 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-09-10$39.09/sh−98→ 1,673,461 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-09-09$38.42/sh−24,753→ 1,678,461 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-09-08$38.34/sh−11,742→ 1,705,218 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-09-08$39.11/sh−2,004→ 1,703,214 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-07-12$38.24/sh−1,501→ 1,716,960 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-06-17$39.76/sh−4,255→ 1,718,461 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-06-17$38.55/sh−1,000→ 1,722,716 total

Companies

Recent Filings

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVE E

SEATTLE, WA, 98109

View on SEC.gov